Karthik Radhakrishnan - Net Worth and Insider Trading

Karthik Radhakrishnan Net Worth

The estimated net worth of Karthik Radhakrishnan is at least $72,649 dollars as of 2025-07-24. Karthik Radhakrishnan is the CFO of Monopar Therapeutics Inc and owns about 1,550 shares of Monopar Therapeutics Inc (MNPR) stock worth over $72,649. Details can be seen in Karthik Radhakrishnan's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Karthik Radhakrishnan has not made any transactions after 2024-10-28 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data
Unlimited Filters in All-in-One Stock Screener
Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Quick Customer Support
And Much More...

Transaction Summary of Karthik Radhakrishnan

To

Karthik Radhakrishnan Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Karthik Radhakrishnan owns 1 companies in total, including Acer Therapeutics Inc (ACER) .

Click here to see the complete history of Karthik Radhakrishnan’s form 4 insider trades.

Insider Ownership Summary of Karthik Radhakrishnan

Ticker Company Transaction Date Type of Owner
ACER Acer Therapeutics Inc 2013-03-29 Chief Financial Officer

Karthik Radhakrishnan Latest Holdings Summary

Karthik Radhakrishnan currently owns a total of 1 stock. Karthik Radhakrishnan owns 1,550 shares of Monopar Therapeutics Inc (MNPR) as of October 28, 2024, with a value of $72,649.

Latest Holdings of Karthik Radhakrishnan

Ticker Company Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
MNPR Monopar Therapeutics Inc 2024-10-28 1,550 46.87 72,649

Holding Weightings of Karthik Radhakrishnan


Karthik Radhakrishnan Form 4 Trading Tracker

According to the SEC Form 4 filings, Karthik Radhakrishnan has made a total of 1 transactions in Monopar Therapeutics Inc (MNPR) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Monopar Therapeutics Inc is the acquisition of 1,550 shares on October 28, 2024, which cost Karthik Radhakrishnan around $25,188.

Insider Trading History of Karthik Radhakrishnan

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Karthik Radhakrishnan Trading Performance

GuruFocus tracks the stock performance after each of Karthik Radhakrishnan's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Karthik Radhakrishnan is 134.55%. GuruFocus also compares Karthik Radhakrishnan's trading performance to market benchmark return within the same time period. The performance of stocks bought by Karthik Radhakrishnan within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Karthik Radhakrishnan's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Karthik Radhakrishnan

Average Return

No transaction record over 1 Year.

Outperforming Transactions

No transaction record over 1 Year.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 16.1 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) 13.09 LIMIT LIMIT LIMIT LIMIT LIMIT

Karthik Radhakrishnan Ownership Network

Ownership Network List of Karthik Radhakrishnan

No Data

Ownership Network Relation of Karthik Radhakrishnan

Insider Network Chart


Karthik Radhakrishnan Owned Company Details

What does Acer Therapeutics Inc do?

Who are the key executives at Acer Therapeutics Inc?

Karthik Radhakrishnan is the Chief Financial Officer of Acer Therapeutics Inc. Other key executives at Acer Therapeutics Inc include director & President and Chief Executive Chris Schelling , Chief Operating Officer Tanya Hayden , and Chief Medical Officer Adrian W Quartel .

Acer Therapeutics Inc (ACER) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Acer Therapeutics Inc (ACER) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Acer Therapeutics Inc (ACER) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Acer Therapeutics Inc (ACER)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Acer Therapeutics Inc Insider Transactions

No Available Data

Karthik Radhakrishnan Mailing Address

Above is the net worth, insider trading, and ownership report for Karthik Radhakrishnan. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Karthik Radhakrishnan's mailing address is: The Woodlands Tx 77382.